Floatz logo

Therapeutic Asset Ratings

130 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
[225ac]-fpi-2068
Head and Neck Squamous Cell Carcinoma
AstraZenecaP1C (37)
ai-061
Head and Neck Squamous Cell Carcinoma
OncoC4, Inc.P1C (37)
Anti-Cd70-Car-T Cells
Head and Neck Squamous Cell Carcinoma
Zhejiang UniversityP1C (37)
Autologous Anti-Cd19 Car-Expressing T Lymphocytes
Head and Neck Squamous Cell Carcinoma
Anusha KalbasiP1C (37)
Autologous, Engineered T Cells Targeting Tp53 R175H
Head and Neck Squamous Cell Carcinoma
AstraZenecaP1C (37)
Azirkitug
Head and Neck Squamous Cell Carcinoma
AbbVieP1C (37)
Bl-M24D1
Head and Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P1C (37)
Budigalimab
Head and Neck Squamous Cell Carcinoma
AbbVieP1C (37)
Cadvec
Head and Neck Squamous Cell Carcinoma
Baylor College of MedicineP1C (37)
cht101
Head and Neck Squamous Cell Carcinoma
Zhejiang UniversityP1C (37)
Clsp-1025
Head and Neck Squamous Cell Carcinoma
Clasp Therapeutics, Inc.P1C (37)
Ctx-8371
Head and Neck Squamous Cell Carcinoma
Compass TherapeuticsP1C (37)
Drug: Ibi3028
Head and Neck Squamous Cell Carcinoma
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.P1C (37)
Emunkitug
Head and Neck Squamous Cell Carcinoma
HiFiBiO TherapeuticsP1C (37)
Fpi-2053
Head and Neck Squamous Cell Carcinoma
AstraZenecaP1C (37)
ft836
Head and Neck Squamous Cell Carcinoma
Fate TherapeuticsP1C (37)
[Ga-68]-PNT6555
Head and Neck Squamous Cell Carcinoma
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and CompanyP1C (37)
hh160
Head and Neck Squamous Cell Carcinoma
Huahui HealthP1C (37)
Hryz-T101
Head and Neck Squamous Cell Carcinoma
HRYZ Biotech Co.P1C (37)
Hryz-T101 Tcr-T Cell
Head and Neck Squamous Cell Carcinoma
HRYZ Biotech Co.P1C (37)
ide034
Head and Neck Squamous Cell Carcinoma
IDEAYA BiosciencesP1C (37)
il13ralpha2-specific hinge-optimized 4-1bb-co-stimulatory car/truncated cd19-expressing autologous tn/mem cells
Head and Neck Squamous Cell Carcinoma
Anusha KalbasiP1C (37)
Immunoglobulin G1, anti-(human CC chemokine receptor CCR8) (human monoclonal CHS114 ?1-chain), disulfide with human monoclonal CHS114 ?-chain, dimer
Head and Neck Squamous Cell Carcinoma
Coherus Oncology, Inc.P1C (37)
Immunoglobulin G1 [de-C-terminal-lysine], anti-(human epidermal growth factor receptor) (human-Mus musculus clone BCA101 ?1-chain), disulfide with human-Mus musculus clone BCA101 ?-chain fusion protein with peptide linker (GGGGS)3 fusion protein with 23-159-transforming growth factor ? receptor TGFBR2 (human), dimer
Head and Neck Squamous Cell Carcinoma
Bicara TherapeuticsP1C (37)
immunoglobulin G1-kappa, anti-[Homo sapiens TNFRSF4 (tumor necrosis factor receptor (TNFR) superfamily member 4, OX40, CD134)], Homo sapiens monoclonal antibody
Head and Neck Squamous Cell Carcinoma
HiFiBiO TherapeuticsP1C (37)
Showing 76 to 100 of 130 assets
PreviousPage 4 of 6Next